Oxcarbazepine
- TRADE NAMES: Oxtellar XR (Supernus); Trileptal (Novartis)
- INDICATIONS: Partial epileptic seizures
- CLASS: Anticonvulsant, CYP3A4 inducer, Mood stabilizer
- HALF-LIFE: 1–2.5 hours
Alcohol, Antipsychotics, Bictegravir/Emtricitabine/Tenofovir Alafenamide, Carbamazepine, Chloroquine, Clopidogrel, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Cyclosporine, CYP3A4 substrates, Doravirine, Doravirine/Lamiduvine/Tenofovir Disoproxil, Dronedarone, Emtricitabine/Rilpivirine/Tenofovir Alafenamide, Eslicarbazepine, Everolimus, Exemestane, Guanfacine, Hydroxychloroquine, Imatinib, Ixabepilone, Ledipasvir & Sofosbuvir, Levomepromazine, Levonorgestrel, MAO inhibitors, Maraviroc, Mefloquine, Nifedipine, Nilotinib, Nisoldipine, Oral Contraceptives, Orlistat, Pazopanib, Perampanel, Phenobarbital, Phenytoin, Praziquantel, Ranolazine, Rilpivirine, Risperidone, Romidepsin, Saxagliptin, Selegiline, Simeprevir, Sofosbuvir, Sofosbuvir & Velpatasvir, Sofosbuvir/Velpatasvir/Voxilaprevir, Sorafenib, SSRIs, St John's Wort, Tadalafil, Tenofovir Alafenamide, Thiazide diuretics, Tolvaptan, Tricyclic antidepressants, Ulipristal, Valproic Acid, Zuclopenthixol
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
Page last updated 10/27/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
